TABLE 1.
2008, % | 2009, % | 2010, % | Change From Status Quo, % | 2015, % | Change From Status Quo, % | 2020, % | Change From Status Quo, % | |
Status quo | 20.1 | 19.9 | 19.6 | 18.6 | 17.5 | |||
Increase in QAs | ||||||||
By 25% | 20.1 | 19.6 | 19.2 | −2.1 | 17.7 | −4.7 | 16.5 | −5.8 |
By 50% | 20.1 | 19.4 | 18.8 | −4.2 | 16.9 | −9.2 | 15.6 | −11.1 |
By 100% | 20.1 | 19.0 | 18.0 | −8.3 | 15.3 | −17.4 | 13.9 | −20.8 |
Increase in TxUse | ||||||||
By 50% | 20.1 | 19.8 | 19.4 | −0.9 | 18.2 | −2.1 | 17.1 | −2.5 |
By 100% | 20.1 | 19.7 | 19.3 | −1.9 | 17.8 | −4.1 | 16.7 | −4.8 |
Increase in QAs and TxUse | ||||||||
By 50% and 50% | 20.1 | 19.3 | 18.5 | −5.6 | 16.3 | −11.9 | 15.0 | −14.3 |
By 100% and 100% | 20.1 | 18.6 | 17.3 | −11.9 | 14.1 | −23.9 | 12.6 | −27.9 |
Increase in TxEffa | ||||||||
By 50% | 20.1 | 19.7 | 19.3 | −1.8 | 17.8 | −4.0 | 16.7 | −4.7 |
By 100% | 20.1 | 19.5 | 18.9 | −3.6 | 17.1 | −7.8 | 15.9 | −9.2 |
Increase in QAs and TxEff | ||||||||
By 50% and 50% | 20.1 | 19.1 | 18.3 | −6.9 | 15.9 | −14.5 | 14.5 | −17.2 |
By 100% and 100% | 20.1 | 18.2 | 16.6 | −15.2 | 13.1 | −29.5 | 11.6 | −33.9 |
Increase in TxUse and TxEff | ||||||||
By 50% and 50% | 20.1 | 19.5 | 18.9 | −3.7 | 17.1 | −7.8 | 15.9 | −9.2 |
Increase in QAs, TxUse, and TxEff | ||||||||
By 50%, by 50%, and by 50% | 20.1 | 18.8 | 17.8 | −9.6 | 14.9 | −19.5 | 13.5 | −22.8 |
By 100%, by 100%, and by 100% | 20.1 | 17.0 | 14.7 | −25.1 | 10.4 | −44.1 | 9.0 | −48.9 |
Increase in QAs, TxUse, and TxEff, with 0% decay rate | ||||||||
By 50%, by 50%, and by 50% | 20.1 | 18.8 | 17.7 | −10.0 | 14.0 | −24.7 | 11.7 | −33.5 |
By 100%, by 100%, and by 100% | 20.1 | 17.0 | 14.5 | −26.1 | 8.7 | −53.0 | 6.3 | −63.8 |
Increase in QAs, TxUse, and TxEff with 25% decay rate | ||||||||
By 50%, by 50%, and by 50% | 20.1 | 18.8 | 17.9 | −8.9 | 15.9 | −14.2 | 14.9 | −14.9 |
By 100%, by 100%, and by 100% | 20.1 | 17.0 | 15.0 | −23.5 | 12.3 | −33.6 | 11.5 | −34.2 |
Note. QA = quit attempts; TxEff = treatment effectiveness; TxUse = treatment use.
Such as reduced relapse.